INDORAMA — Indo Rama Synthetics (India) Balance Sheet
0.000.00%
- IN₹25.47bn
- IN₹30.11bn
- IN₹49.10bn
Annual balance sheet for Indo Rama Synthetics (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 122 | 560 | 240 | 246 | 168 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,408 | 5,517 | 6,314 | 6,897 | 9,465 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10,387 | 12,956 | 12,785 | 13,369 | 16,723 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,367 | 11,072 | 13,224 | 12,997 | 12,742 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 21,055 | 27,130 | 29,069 | 29,357 | 32,441 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12,691 | 15,158 | 21,069 | 21,533 | 22,228 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 15,053 | 21,403 | 25,388 | 25,675 | 27,249 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 6,002 | 5,727 | 3,681 | 3,682 | 5,192 |
| Total Liabilities & Shareholders' Equity | 21,055 | 27,130 | 29,069 | 29,357 | 32,441 |
| Total Common Shares Outstanding |